Skip to main content
. 2018 Nov 8;45:83–87. doi: 10.1007/8904_2018_145

Table 1.

Outcomes in male infants with OTC deficiency due to contiguous gene deletion syndromes

Reference Deletion size, OMIM genes Number of affected males Positive family history? Age at death
Gallant et al. (2015) 1.87-Mb deletion of XK, CYBB, RPGR, OTC, and TSPAN7 One No 7 days old
Jain-Ghai et al. (2015) 0.74-Mb deletion of RPGR, OTC, and TSPAN7 One Yes – older sister with known OTC deficiency 14 months old
Ono et al. (2010) 1-Mb deletion of RPGR, OTC, and TSPAN7 One No 16 days old
Quental et al. (2009) 209-kb deletion of OTC and part of TSPAN7 One No Several days old
Deardoff et al. (2008) 3.9-Mb deletion of XK, CYBB, RPGR, and exons 1–8 of OTC Two brothers Yes – prenatal diagnosis made in second infant 5 days old (1st child)
12 weeks old (2nd child)
Arranz et al. (2007) 0.5-Mb deletion of RPGR, OTC, and TSPAN7 One Yes – mother with known OTC deficiency 17 days old
Segues et al. (1995) Both families had deletions of CYBB, RPGR, and OTC Three: two brothers and one unrelated Yes – one family had multiple male neonatal deaths 2 days old (both brothers)
Several days old
Old et al. (1985) Xp21 deletion on karyotype, spanning NROB1 through OTC One No 36 h old